Precursor Condition
Low Grade Squamous Intraepithelial Neoplasia
CI-CAN-00003069LSILExplore in graph →
Precursor6 active trials
- NCIt
- C8335
Loading cancer entity…
Precursor Condition
CI-CAN-00003069LSILExplore in graph →
Clinical trials
25 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05916911 | Evaluation Of The Efficacy Of The Combination Of GLIZIGEN® Oral Solution 1/Day And Vaginal Gel 1/Night For 2 Months In Patients With Cervical Intraepithelial Neoplasia Grade 1 (LSIL/CIN-1) Caused By High-Risk Human Papillomavirus (HPV-AR) | unknown | Phase 4 | 120 | Catalysis SLINDUSTRY | 1 | Feb 7, 2024 | clinicaltrials |
| NCT05808816 | "Lactobacillus Crispatus M247, LSIL and Microbiota" | unknown | Phase 4 | 90 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Apr 11, 2023 |
| clinicaltrials |
Data updated 22 days agoSource updated Feb 7, 2024source: clinicaltrials